| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.096 | 0.05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |